Hormone Vitality Peptides

Hormone vitality peptides are compounds investigated for their interactions with endocrine signalling, reproductive hormone pathways and related biological regulatory mechanisms.

Research in this area includes naturally occurring signalling peptides, synthetic peptide analogues and experimental bioregulators. Different compounds interact with distinct receptors and molecular pathways, making them relevant to specialised laboratory investigations.

Several compounds have attracted interest in hormone and reproductive biology research, including Kisspeptin-10, PT-141, Melanotan 2, Ovagen and Testagen.

Kisspeptin-10 is investigated in reproductive hormone signalling, while PT-141 and Melanotan 2 are studied for their interactions with melanocortin receptors. Ovagen and Testagen belong to a separate group of short peptide bioregulators associated with experimental tissue-specific research.

Kisspeptin-10 is a synthetic peptide fragment studied for its involvement in reproductive endocrine signalling.

It interacts with the KISS1 receptor, a component of the biological pathway regulating gonadotropin-releasing hormone (GnRH) secretion.

Researchers investigate Kisspeptin-10 to understand the relationship between hypothalamic signalling, luteinising hormone (LH), follicle-stimulating hormone (FSH) and reproductive physiology.

PT-141, also known as Bremelanotide, and Melanotan 2 are synthetic peptides investigated for their activity at melanocortin receptors.

Melanotan 2 is a non-selective melanocortin receptor agonist studied across multiple receptor-mediated pathways, including pigmentation and central nervous system signalling.

PT-141 was developed from melanocortin peptide research and has a more specifically characterised clinical development history.

Although they share related molecular origins, the compounds have different pharmacological profiles and research applications.

Ovagen and Testagen are short synthetic peptides associated with the Khavinson peptide bioregulator research tradition.

Ovagen has been examined in research literature concerning hepatic and reproductive tissue biology, while Testagen is associated with experimental investigations involving testicular tissue and cellular regulatory pathways.

Both compounds remain subjects of specialised research, and their proposed biological activities should not be interpreted as established clinical benefits.

Researchers interested in similar compounds can explore our wider Peptide Bioregulators collection.

Hormone research peptides encompass a broad range of compounds investigated across endocrine and receptor-mediated signalling pathways.

Growth hormone secretagogues represent a more specific research group, typically studied for their interactions with pathways regulating growth hormone secretion.

For example, Kisspeptin-10 is investigated in reproductive endocrine signalling, whereas Ipamorelin and GHRP-2 are researched in relation to ghrelin receptor activity and growth hormone regulation.

Explore our Growth & Performance research peptides for compounds associated with these pathways.

Specialist suppliers such as Coridion Sciences offer a range of hormone-related research peptides for legitimate laboratory applications, subject to the legal status and applicable restrictions of individual compounds.

Researchers should assess product identity, purity, stated concentration, batch traceability and available analytical documentation before selecting materials for experimental investigation.

Regulatory approval depends on the individual compound, formulation, indication and jurisdiction.

For example, Bremelanotide has a specific approved medical application in the United States, but that does not mean laboratory formulations are authorised medicines or suitable for human administration.

Other compounds in this category remain experimental or have limited clinical evidence.

Coridion Sciences products are supplied strictly for research purposes and are not intended for human consumption or therapeutic use.